NCT04800445

Brief Summary

To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 16, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2022

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

8 months

First QC Date

February 26, 2021

Last Update Submit

August 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Salivary c reactive protein in neonatal sepsis

    Salivary C reactive protein of value as non invasive procedure in diagnosis of neonatal sepsis

    28 days

Secondary Outcomes (1)

  • Mean platelet volume

    28 days

Study Arms (2)

Case group of fullterm neonates with neonatal sepsis

Diagnostic Test: Salivary CRP

Healthy fullterm neonates

Diagnostic Test: Salivary CRP

Interventions

Salivary CRPDIAGNOSTIC_TEST

Salivary C reactive protein in neonatal sepsis

Case group of fullterm neonates with neonatal sepsisHealthy fullterm neonates

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Full term neonates of both genders from birth to the 28th day of life who were admitted to Cairo University NICU with clinical features of either early- or late-onset neonatal sepsis diagnosed by culture, CRP more than 10 ,and has three or more the clinical findings of sepsis were enrolled in this study. Neonates with no symptoms or signs suggestive 0f sepsis who had been hospitalized In Cairo University Nicu . Serum CRP level for neonates in this group was negative (CRP \< 10 mg/L) as control group.

You may qualify if:

  • \- Full term neonates of both genders from birth to the 28th day of life diagnosed with sepsis by history, clinical findings, laboratory findings, and blood culture. The clinical findings included the presence of three or more of the following:
  • (1) temperature instability (hypothermia, hyperthermia) .
  • (2) respiratory alterations (grunting, intercostal retractions, apnea, tachypnea, cyanosis) .
  • (3) cardiovascular alterations (bradycardia, tachycardia, poor perfusion, hypotension) .
  • (4) neurologic alterations (hypotonia, lethargy, seizures)
  • (5) gastrointestinal alterations (feeding intolerance, abdominal distension). CRP values \>10 mg/L were considered to be positive.

You may not qualify if:

  • \- Preterm neonates .
  • Neonates with CNS malformations, metabolic disorders, chromosomal abnormalities, intrauterine growth restriction, or birth asphyxia were excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine

Cairo, Almanyal, 11562, Egypt

Location

MeSH Terms

Conditions

Neonatal Sepsis

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Emergency medicine and traumatology resident in sharq el madina hospital

Study Record Dates

First Submitted

February 26, 2021

First Posted

March 16, 2021

Study Start

April 4, 2020

Primary Completion

December 4, 2020

Study Completion

January 10, 2022

Last Updated

August 9, 2021

Record last verified: 2021-08

Locations